HALO logo
halo search icon
ABBV
AbbVie, Inc.

ABBV · AbbVie, Inc.

259.36

USD
2.44 (0.95%)
24/07/2026 04:10:00 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$453.92B

PE

74.30

EV/EBITDA

15.1

DIV Yield

3.5%

Payout Ratio

200%

MQV Rating

3Neutral

As at 24/07/2026 04:10:00 PM

Price Chart

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

  • All-Companies
  • All-Consensus
  • ALL-Recommendations
  • HALO 200
  • HALO 500
  • HALO All
  • HALO Capital Efficiency
  • HALO Price Momentum
  • Hammer Bullish
  • Near 52 Week High
  • Near Resistance
  • Near Resistance (Realtime)
  • Recent Price upgrade
  • Short Term Trend - Long

Key Fundamentals

EPS 3 yr Growth

-63.00%

EBITDA Margin

44.40%

Operating Cashflow

$18,806m

Free Cash Flow Return

29.50%

ROIC

6.60%

Interest Coverage

8.50

Quick Ratio

0.60

Performance

52 weeks range

Low 187.62 - 261.64

Trade Value (12mth)

US$354,943,001.00

1 week

0.99%

1 month

9.38%

YTD

12.04%

1 year

34.63%

All time high

261.64

Additional Data

Shares Outstanding (Fully Diluted)

1,769m

HALO Sector

Healthcare

Next Company Report Date

03-Feb-27

Next Ex Dividend Date

15-Jul-26

Next Dividend Pay Date

14-Aug-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Strong

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Strong

Earnings

Neutral

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
07 July 26EDG
07 July 26EDG
25 June 26EDG
22 June 26EDG
13 May 26EDG

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current share price of AbbVie, Inc. (ABBV:NYS) is USD$259.36.
2
What is the 52-week high share price for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The 52-week high share price for AbbVie, Inc. (ABBV:NYS) is USD$261.64.
3
What is the 52-week low share price for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The 52-week low share price for AbbVie, Inc. (ABBV:NYS) is USD$187.62.
4
What is the dividend yield for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current TTM dividend payout for AbbVie, Inc. (ABBV:NYS) is 3.50.
5
What was AbbVie, Inc. (ABBV:NYS) last dividend payment?
Halo FAQ
The last dividend payment of AbbVie, Inc. (ABBV:NYS) is USD$1.73.
6
What is the franking level for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
AbbVie, Inc. (ABBV:NYS) has a franking level of 0.00%.
7
In which sector is AbbVie, Inc. (ABBV:NYS) classified?
Halo FAQ
AbbVie, Inc. (ABBV:NYS) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for AbbVie, Inc. (ABBV:NYS)?
Halo FAQ
The current P/E ratio for AbbVie, Inc. (ABBV:NYS) is 74.30.